(R)-DFV890   Click here for help

GtoPdb Ligand ID: 13782

Synonyms: compound (R)-1 [PMID: 40036600] | DFV-890 | IFM-2427 | IFM2427
PDB Ligand Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: The discovery of (R)-DFV890 is reported in [3]. It is an NLRP3 inflammasome inhibitor that is intended for anti-inflammatory action.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 3
Rotatable bonds 5
Topological polar surface area 150.82
Molecular weight 420.55
XLogP 0.45
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC(C)(C1=NC=C(S1)[S@@](=NC(=O)NC2=C3CCCC3=CC4=C2CCC4)(=O)N)O
Isomeric SMILES CC(C)(O)C1=NC=C([S@](N)(=O)=NC(=O)NC2=C3CCCC3=CC4=C2CCC4)S1
InChI InChI=1S/C19H24N4O3S2/c1-19(2,25)17-21-10-15(27-17)28(20,26)23-18(24)22-16-13-7-3-5-11(13)9-12-6-4-8-14(12)16/h9-10,25H,3-8H2,1-2H3,(H3,20,22,23,24,26)/t28-/m1/s1
InChI Key LHVWNNYPUDZLSH-MUUNZHRXSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

References
1. Gatlik E, Mehes B, Voltz E, Sommer U, Tritto E, Lestini G, Liu X, Pal P, Velinova M, Denney WS et al.. (2024)
First-in-human safety, tolerability, and pharmacokinetic results of DFV890, an oral low-molecular-weight NLRP3 inhibitor.
Clin Transl Sci, 17 (5): e13789. [PMID:38761014]
2. Madurka I, Vishnevsky A, Soriano JB, Gans SJ, Ore DJS, Rendon A, Ulrik CS, Bhatnagar S, Krishnamurthy S, Mc Harry K et al.. (2023)
DFV890: a new oral NLRP3 inhibitor-tested in an early phase 2a randomised clinical trial in patients with COVID-19 pneumonia and impaired respiratory function.
Infection, 51 (3): 641-654. [PMID:36104613]
3. Shen DM, Byth KF, Bertheloot D, Braams S, Bradley S, Dean D, Dekker C, El-Kattan AF, Franchi L, Glick GD et al.. (2025)
Discovery of DFV890, a Potent Sulfonimidamide-Containing NLRP3 Inflammasome Inhibitor.
J Med Chem, 68 (5): 5529-5550. [PMID:40036600]